What are the conditions associated with dyslipidemia pre-pregnancy that put women at greater risk for complications? What is the long term effect of having an obstetrical complication as CVD Risk for the mother and fetus? And, what is the major concern for hypertriglyceridemia in Pg and how do you treat it? Dr. Alan Brown, host, welcomes Dr. Robert A. Wild, who will address these questions and more during this discussion of Lipid Luminations. Dr. Wild is Professor of Reproductive Endocrinology, Obstetrics and Gynecology, Medicine, Family Medicine & Biostatistics and Epidemiology at the University of Oklahoma. And, he is Chief of the Gynecology Service at the VA Medical Center in Oklahoma City, OK.
Managing CVD in Women During Childbearing Years
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What are the conditions associated with dyslipidemia pre-pregnancy that put women at greater risk for complications? What is the long term effect of having an obstetrical complication as CVD Risk for the mother and fetus? And, what is the major concern for hypertriglyceridemia in Pg and how do you treat it? Dr. Alan Brown, host, welcomes Dr. Robert A. Wild, who will address these questions and more during this discussion of Lipid Luminations. Dr. Wild is Professor of Reproductive Endocrinology, Obstetrics and Gynecology, Medicine, Family Medicine & Biostatistics and Epidemiology at the University of Oklahoma. And, he is Chief of the Gynecology Service at the VA Medical Center in Oklahoma City, OK.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?